The effect of fucoxanthin on the development of CCl<sub>4</sub>-induced liver fibrosis

Background. According to current concepts regarding hepatic fibrosis, myofibroblast differentiation from stellate cells, regulated by transforming growth factor-β (TGF-β), is a key step in its pathogenesis. Hence, inhibition of TGF-β-dependent activation of hepatic stellate cells has been suggested...

書誌詳細
出版年:	Фундаментальная и клиническая медицина
主要な著者:	V. N. Slautin, D. Yu. Grebnev, I. Yu. Maklakova, S. V. Sazonov, I. V. Gavrilov, E. I. Gavrilova
フォーマット:	論文
言語:	ロシア語
出版事項:	Kemerovo State Medical University 2023-06-01
主題:	fucoxanthin liver fibrosis hepatic stellate cells myofibroblasts
オンライン･アクセス:	https://fcm.kemsmu.ru/jour/article/view/710

類似資料

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
著者:: Oliver Krenkel, 等
出版事項: (2019-05-01)

Noncoding RNA-Mediated Epigenetic Regulation in Hepatic Stellate Cells of Liver Fibrosis
著者:: Ruoyu Gao, 等
出版事項: (2024-08-01)

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
著者:: Bedair Dewidar, 等
出版事項: (2019-11-01)

“The Good, the Bad, and the Ugly” – About Diverse Phenotypes of Hepatic Stellate Cells in the LiverSummary
著者:: Alexandra Bogomolova, 等
出版事項: (2024-01-01)

Editorial: Liver myofibroblasts
著者:: Jiri Kanta, 等
出版事項: (2016-08-01)

Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells
著者:: Yang Li, 等
出版事項: (2021-12-01)

T cells and liver fibrosis
著者:: Ruonan Sun, 等
出版事項: (2022-09-01)

Modern concepts on pathogenetic mechanisms of liver fibrosis
著者:: N. A. Efremova, 等
出版事項: (2023-04-01)

The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration
出版事項: (2016-03-01)

Interleukin-19 Gene-Deficient Mice Promote Liver Fibrosis via Enhanced TGF-β Signaling, and the Interleukin-19-CCL2 Axis Is Important in the Direction of Liver Fibrosis
著者:: Naoshige Ono, 等
出版事項: (2023-07-01)

Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update
著者:: Tea Omanovic Kolaric, 等
出版事項: (2023-05-01)

Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
著者:: Yufei Yan, 等
出版事項: (2021-08-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
著者:: SUN Lijie, HAO Dandan
出版事項: (2024-01-01)

Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis
著者:: Jin Joo Cha, 等
出版事項: (2020-10-01)

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
著者:: Natascha Roehlen, 等
出版事項: (2020-04-01)

Genetic Characterization of Rat Hepatic Stellate Cell Line PAV-1
著者:: Kiara Gäberlein, 等
出版事項: (2023-06-01)

Genetic Characterization of Rat Hepatic Stellate Cell Line HSC-T6 for In Vitro Cell Line Authentication
著者:: Indrajit Nanda, 等
出版事項: (2022-05-01)

Rat Hepatic Stellate Cell Line CFSC-2G: Genetic Markers and Short Tandem Repeat Profile Useful for Cell Line Authentication
著者:: Indrajit Nanda, 等
出版事項: (2022-09-01)

Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts
著者:: Norifumi eKawada
出版事項: (2015-11-01)

Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
著者:: Kaumudi Somnay, 等
出版事項: (2024-09-01)

Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury
著者:: Wenjun Zhang, 等
出版事項: (2021-08-01)

Melatonin Attenuates Dysregulation of the Circadian Clock Pathway in Mice With CCl4-Induced Fibrosis and Human Hepatic Stellate Cells
著者:: Bárbara González-Fernández, 等
出版事項: (2018-05-01)

Leonurine Attenuates CCl4-Induced Hepatic Fibrosis in Mice via the Hippo-YAP Pathway
著者:: Wang P, 等
出版事項: (2025-07-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
著者:: GONG Xiaoqian, 等
出版事項: (2025-04-01)

RANKL inhibits activation of hepatic stellate cells during hepatic fibrosis in mice
著者:: ZHOU Lijia, 等
出版事項: (2023-01-01)

Involvement of epithelial-mesenchymal transition in liver fibrosis
著者:: Kangkang Yu, 等
出版事項: (2018-01-01)

MicroRNAs as critical regulators in liver fibrosis
著者:: Xiaolin Wang, 等
出版事項: (2023-09-01)

Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway
著者:: Lenan Xu, 等
出版事項: (2023-03-01)

The different effects of four adenosine receptors in liver fibrosis
著者:: Lan Yang, 等
出版事項: (2024-09-01)

Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis
著者:: Simon Hohenester, 等
出版事項: (2020-01-01)

Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation
著者:: Ayana Fujiwara, 等
出版事項: (2024-08-01)

DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling
著者:: Qing-Qing Liu, 等
出版事項: (2024-04-01)

Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice
著者:: Wu Y, 等
出版事項: (2019-08-01)

ATF3‐mediated transactivation of CXCL14 in HSCs during liver fibrosis
著者:: Xinmiao Li, 等
出版事項: (2024-10-01)

Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
著者:: Liangtao Zhao, 等
出版事項: (2024-12-01)

Furin inhibits HSCs activation and ameliorates liver fibrosis by regulating PTEN‐L/PINK1/parkin mediated mitophagy in mouse
著者:: Yan‐Wei Song, 等
出版事項: (2025-05-01)

Fucoxanthin improves serum lipids, liver metabolism and gut microbiota in hyperlipidemia mice
著者:: Yonghui Zhou, 等
出版事項: (2025-01-01)

Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy
著者:: Hong Li, 等
出版事項: (2023-07-01)

MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy
著者:: Dou Shi-Ying, 等
出版事項: (2021-11-01)

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
著者:: Zui Tan, 等
出版事項: (2021-09-01)